TABLE 3.
Changes in anthropometric and body-composition measures from baseline to follow-up1
| CLA (n = 28) |
Placebo (n = 25) |
P for between-group change | |||||
| Month 0 | Follow-up | Change | Month 0 | Follow-up | Change | ||
| Height (cm) | 138 ± 8 | 141 ± 8 | 3 ± 12 | 136 ± 8 | 139 ± 7 | 3 ± 22 | 0.2 (NS) |
| Body weight (kg) | 45 ± 14 | 48 ± 14 | 3.2 ± 1.92 | 41 ± 7.2 | 45 ± 7.8 | 3.7 ± 2.32 | 0.4 (NS) |
| BMI (kg/m2) | 23.3 ± 4.6 | 23.8 ± 4.7 | 0.5 ± 0.82 | 22.6 ± 5.3 | 23.3 ± 2.9 | 1.1 ± 1.12 | 0.04 |
| BMI z score | 1.83 ± 0.48 | 1.81 ± 0.49 | −0.03 ± 0.16 | 1.70 ± 0.47 | 1.75 ± 0.50 | 0.05 ± 0.23 | 0.2 (NS) |
| Fat mass (kg) | 15.1 ± 7.0 | 16.0 ± 7.3 | 0.8 ± 1.42 | 13.0 ± 3.8 | 14.7 ± 4.3 | 1.8 ± 1.32 | 0.01 |
| Body fat (%) | 32.7 ± 5.0 | 32.2 ± 5.0 | −0.5 ± 2.1 | 31.1 ± 6.0 | 32.4 ± 6.0 | 1.3 ± 1.82 | 0.001 |
| Fat-free mass (kg) | 29.7 ± 6.9 | 32.1 ± 7.1 | 2.4 ± 1.22 | 28.3 ± 4.6 | 30.0 ± 4.8 | 1.9 ± 1.32 | 0.2 (NS) |
| Fat-free mass (%) | 67.3 ± 5.0 | 67.8 ± 5.0 | 0.5 ± 2.1 | 68.9 ± 6.0 | 67.6 ± 6.0 | −1.3 ± 1.82 | 0.001 |
| Peripheral fat (%) | 22.8 ± 2.3 | 21.8 ± 2.6 | −1.2 ± 1.02 | 21.7 ± 3.2 | 22.2 ± 3.1 | 0.5 ± 1.22 | <0.001 |
| Abdominal fat (%) | 9.1 ± 1.4 | 9.1 ± 1.4 | −0.1 ± 0.9 | 8.8 ± 1.9 | 9.1 ± 1.7 | 0.4 ± 0.63 | 0.02 |
| BMC, head excluded (kg) | 1.24 ± 0.23 | 1.28 ± 0.25 | 0.05 ± 0.03 | 1.17 ± 0.19 | 1.26 ± 0.20 | 0.07 ± 0.032 | 0.04 |
1
All values are means ± SDs. Subjects are those who completed follow-up measures with outliers beyond 3 SD from the mean removed. CLA, conjugated linoleic acid; BMC, bone mineral content.
2,3
Significant within-group change comparison: 2P ≤ 0.05, 3P ≤ 0.01.